Status:
COMPLETED
Role of Vitamin D Therapy in Recovery From Early Neonatal Sepsis (Randomized Controlled Trial)
Lead Sponsor:
Ain Shams University
Conditions:
Importance of Vitamin D Therapy in Treatment of Neonatal Sepsis
Eligibility:
All Genders
3-7 years
Phase:
PHASE3
Brief Summary
Neonatal sepsis is still a major cause of morbidity and mortality despite major advances in neonatal intensive care units. Early-onset sepsis (EOS) is an infection of the blood acquired vertically fro...
Detailed Description
Subjects: This is a randomized controlled trial (RCT) conducted on sixty (66) full term newborns with clinical and laboratory findings of early onset of sepsis (EOS) and admitted to the Neonatal Inte...
Eligibility Criteria
Inclusion
- - full term newborns with clinical and laboratory findings of early onset of sepsis (EOS).
Exclusion
- Preterm newborn, NPO neonates , infants with maternal risk factors , such as clinical and/or histological chorioamnionitis, neonates delivered at home ,neonates to mothers with premature rupture of membrane, and major congenital abnormalities which may be predisposing factors for development of EOS.
Key Trial Info
Start Date :
August 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 27 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT05969327
Start Date
August 14 2018
End Date
December 27 2022
Last Update
August 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayada Ahmad Mohamed
Zagazig, Egypt